End-stage liver disease (ESLD)
Conditions
Interventions
Liver transplantation Observation group:None
Sponsors
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who have received liver transplants at the project's leading unit and co-construction units since April 2025 2. There are no serious complications after the operation, and the expected survival time is >=3 months 3. Postoperative compliance was good, and anti-rejection drugs and other combined medications were taken as prescribed by the doctor 4. The informed consent form is voluntarily signed by the individual or their entrusted agent or guardian
Exclusion criteria
Exclusion criteria: 1. Perioperative death (within 30 days after surgery) 2. Patients undergoing autologous liver transplantation 3. Patients who were considered unsuitable to participate in this study by the researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival rates at 1 year, 3 years and 5 years after the operation;Graft survival rate (loss of graft function or patient death; | — |
Secondary
| Measure | Time frame |
|---|---|
| Immunosuppressation-related indicators;Quality of life indicators;Graft function indicators;Incidence of complications; | — |
Countries
China
Contacts
Public ContactXia Qiang
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed